SCIENTIFIC PROGRAMME

2 December 2020, Wednesday

16:00-16:30

Session I: Opening Session
Markers for the Systemic Management of Early and Advanced Colon Cancer

Chairs:
Suayib Yalcin, Philip Agop Philip, Ilias Athanasiadis
16:00-16:15

  • Prognostic and Predictive Markers for Stage 2 and 3 CRC
    Claus Henning Köhne

16:15-16:30

  • Marker Driven Treatment in Metastatic Colon Cancer: Where do we Stand
    Axel Grothey

Discussion: Secil Demirkol Canli, Oktay Aktepe, Emrah Erarslan, Hacer Gozde Gul

16:30-16:45 Break
16:45-17:30

Abbott Satellite Symposium
Nutrition for Cancer Patients: Medical Oncologist’s Perspective
Chairs:
Nil Molinas Mandel, Mahmut Gumus
16:45-17:00

  • Principle of Nutrional Support in Gastrointestinal Cancer Patients
    Meltem Halil

17:00-17:05 Abstract 1
17:05-17:10 Abstract 2

17:10-17:30

  • Malnutrition in Cancer: From Medical Oncologists Perspective
    – Suayib Yalcin

Discussion: Yusuf Gunaydin, Yusuf Karakas, Deniz Can Guven, Ramazan Esen

17:30-17:45 Break
17:45-18:50

Session II: Esophageal Cancer Management How Should I Treat in 2020
Chairs:
David Ilson, Faruk Zorlu

17:45-18:05

  • Esophageal Cancer Management: How should I treat in 2020
    Jamal Khader

18:05-18:20

  • Emerging Systemic Treatment Options for Esophageal Cancer
    Huseyin Engin

18:20-18:35

  • Perioperative Chemotherapy or Neoadjuvant Chemadiotherapy for Esophageal Cancers
    Ahmet Bilici

18:35-18:50

  • N ivolumab Plus Chemotherapy Versus Chemotherapy as First-line Treatment for Advanced
    Gastric Cancer/Gastroesophageal Junction Cancer/Esophageal Adenocarcinoma: First Results
    of the CheckMate 649 Study
     
    – Mehmet Ali Nahit Sendur

Discussion: Oktay Aktepe, Hakan Taban, Tulay Kus, Ozlem Ozdemir

18:40-18:55 Break
18:55-20:00

Session III: Role of Age and Gender in the Management of Colon Cancer
Chairs: Handan Onur, Erdem Goker, Zafer Arik
18:55-19:15

  • Elderly Patients with Colon Cancers
    Demetris Papamichael

19:15-19:33

  • Young Patients with Colon Cancers
    Ilias Athanasiadis

19:35-19:55

  • Gender Differences in Colon Cancers
    Marc Peeters

19:55-20:00 Discussion: Cagri Yildirim, Burak Yasin Aktas, Elvina Almuradova, Serkan Yasar

20:00-20:10 Break
20:10-20:40 Session IV: Microbiota and Colon Cancer
Chairs:
Philip Agop Philip, Ilias Athanasiadis, Tezer Kutluk
Speaker: Suayib Yalcin
Discussion: Deniz Can Guven, Burak Yasin Aktas, Seda Kahraman

 

3 December 2020, Thursday

16:00-16:45

Session V: Hepatocellular Tumors
Chairs:
Halis Simsek, Erkan Dogan, Neyran Kertmen
16:00-16:15

  • New Perspectives in Classification of HCC
    Sahin Lacin

16:15-16:35

  • Advances in the Systemic Treatment of Hepatocellular Cancer
    Ahmed Kaseb

Discussion: Feride Yilmaz, Serkan Yasar, Seniz Tutum

16:45-17:00 Break
17:00-17:40

Session VI: Special Issues in GI Oncology
Chairs: Ahmet Demirkazik, Ahmet Ozet

17:00-17:15

  • Adult Vaccination in Patients with GI Cancers During Covid Era
    – Murat Akova

17:15-17:30 

  • Caring Cancer Patients During Covid Pandemia
    – Nermin Talibova

Discussion: Merve Kuday, Berrin Papilla Kundaktepe, Hatice Bolek

17:40-17:55 Break
17:55-19:30

Session VII: Gastric Cancer: Towards More Individualized Approach
Chairs: Mahmut Gumus, Esra Kaytan Saglam, Birol Bostanci
17:55-18:15

  • Adjuvant/Neoadjuvant Therapy in Gastric Cancer:
    – Gokhan Demir

18:15-18:35

  • Role of Radiotherapy as Adjuvant and Neoadjuvant Treatment
    – Pervin Hurmuz

18:35-18:55

  • Advances an the Systemic Treatment of Advanced Gastric Cancer
    – David Ilson

18:55-19:10

  • Management of HER-2 Positive Gastric Cancer
    – Suayib Yalcin

19:10-19:30 

  • Impact of MSI in the Treatment of Gastric and Hepatobiliary Cancers 
    – Ibrahim Halil Sahin

Discussion: Merve Keskinkilic, Ali Aytac

19:30-19:45 Break
19:45-20:45

Session VIII: Management of NETs
Chairs:
Biljana Grozdanovska Angelovska, Philip Agop Philip
19:45-20:05

  • Radionuclide Imaging and Therapy for Neuroendocrine Tumour
    Meltem Caglar Tuncali

20:05-20:20

  • How to Classify and Staging NEN?
    Sibel Erdamar

20:20-20:40

  • Systemic Treatment in Advanced GEPNETS
    Ramon Salazar

Discussion: Ezgi Degerli, Fatih Gurler

4 December, 2020, Friday

12:10-13:20

Session IX: Advanced Colorectal Cancer: A Closer Look on Individualized Treatment

Chairs: Mustafa Ozdogan, Hakan Harputluoglu, Ozlem Er

12:10-12:25

  • Implications of ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Ebru Cilbir

12:25-12:40

  • How to Consider HER-2 Positivity in Metastatic Colon Cancer

Meral Gunaldi

12:40-13:00

  • Resistance Mechanisms for anti VEGF Treatment

Zeki Surmeli

13:00-13:15

  • Resistance Mechanisms for EGFR Monoclonal Antibodies in Colon Cancer

Mutlu Hızal
13:15-13:20 Discussion:Vladimir Nikolic, Fatih Yildiz, Izzet Dogan

13:20-13:30 Break
13:30-14:20

Session X: Polipozis and Nonpolipozis CRC
Chairs:
Timucin Cil, John Souglakos
13:30-15:50

  • Polipozis and Colorectal Cancer: Umut Demirci

13:50-14:10

  • Lynch Syndrome and Colon Cancer: Omer Dizdar

 

14:10-14:20 Discussion: Ferit Aslan, Osman Sutcuoglu, Deniz Kutri

14:20-14:30 Break
14:30-15:10 Lilly Satellite Symposium
Ramucirumab for the Treatment of Metastatic Gastric Cancer
&Clinical Cases
Chair: 
Gokhan Demir
Speaker: 
Ahmet Bilici
15:10-15:15 Break
15:15–15:55

Session XI: Biliary Tract Cancer
Chairs: Necdet Uskent, Ioannis Boukovinas, Ahmed Kaseb

15:15-15:35

  • Systemic Treatment

Shouki Bazarbashi

15:35-15:55

  • New Agents and Strategies on the Horizon in Bile Duct Cancer

Reham Abdel-Wahab
Discussion: Sahin Lacin, Aysegul Ilhan, Ismail Beypinar

15:55-16:05 Break
16:05-16:45 Merck Satellite Symposium
Powerful Start in Ras Wild mCRC
Chair:
Suayib Yalcin
Speaker:
Mario Scartozzi
16:45-16:55 Break
16:55–17:25

Session XII: New Tissue Agnostics Pathways to Target GI Cancers
Chairs: Jesus Garcia Foncillas, Halil Kavgaci
16:55-17:10

  • FGFR Mutation and GI Cancers:

Gamze Gokoz Dogu

17:10-17:25

  • Systemic Treament of GI Cancers with RET Alterations

Bulent Orhan

Discussion: Berrin Papilla Kundaktepe, Emrah Erarslan

17:25-17:35 Break
17:35–18:05 Session XIII: Emerging Role of Biosimilars in Gastrointestinal Oncology
Chairs: Irfan Cicin, Arzu Yaren
Speaker: 
Christopher Twelves
18:05-18:15 Break
18:15–19:10

Session XIV: Summary of the Year
Chairs: Idris Yucel, Nuran Senel Bese, Shouki Bazarbashi
18:15-18:35

  • Update on Adjuvant Therapy in Colon Cancer

John Souglakos

18:35-18:55

  • Update on the First-Line Treament in mCRC

Dirk Arnold

18:55-19:10

  • Global Cancer Control

– Tezer Kutluk

Discussion: Seda Kahraman, Emre Yekeduz, Oguzcan Gumuscubuk, Gurkan Guner

19:10-19:20 Break
19:10-19:55

Session XV: Anal Cancer
Chairs: Ilhan Oztop, Durmus Etiz
19:20-19:40

  • Advances is the Multimodality Treatment for Localized Disease

Ferah Yildiz

19:40-19:55

  • New Systemic Treatment Options for Metastatic Disease

Ece Esin

Discussion: Canan Karan, Oktay Unsal, Ozden Ozer

19:55-20:00

Break

20:00-20:45

SANOFI Satellite Symposium
Second line mCRC: From Clinical Trials to Daily Practice
Speaker:
Ralf-Dieter Hofheinz

5 December, 2020, Saturday

09:00-09:30

Session XVI: Carninoma of Unknown Origin

Chair: Ioannis Boukovinas, Feyyaz Ozdemir
Speaker: 
Nuri Karadurmus

09:30-09:45 Break
09:45-10:30

Session XVII: Understanding the Biology of Colorectal Cancer
Chairs: Berna Oksuzoglu, Demetris Papamichael
09:45-10:00

  • Obesity and Colorectal Carcinogenesis

Mehmet Artac

10:00-10:15

  • NLR and Inflammation Colon Cancer

        – Mehmet Ali Nahit Sendur
10:15-10:30

  • Vitamin D and colon cancer

        – Ofer Purim
Discussion: Ozgul Ekmekcioglu, Yalcin Cirak, Hacer Gozde Gul

10:30-10:45 Break
10:45–11:35

Session XVIII: Optimizing Treatment:
Chairs:
Isil Somali, Coskun Tecimer
10:45-11:00

  • Role of Maintenance Therapy in Advanced CRC

Ali Shamseddine

11:00-11:15

  • Treatment Beyond Second Line: Choosing Patients

        – Cagatay Arslan
11:15-11:30

  • Choosing Chemotherapy Backbone in the Firstline: Does It Matter

        – Axel Grothey
Discussion: Deniz Kutri, Sercan On

11:35-11:45 Break
11:45–12:05

Session XIX: Adjuvant Treatment for Stage 2 Cancer: To treat or Not to Treat

Chair: Ozgur Ozyilkan, Ahmet Ozet
Speaker: Demetris Papamichael

Discussion: Aysegul Ilhan, Oguzcan Gumuscubuk

12:05-12:15 Break
12:15–12:55 Amgen Satellite Symposium
Update on mCRC: Is more Possible for MCRC
Chair: Timucin Cil
Speaker: 
 Marc Peeters
12:55-13:05 Break
13:05–13:40

Session XX: Advanced RAS Mutant Colorectal Cancer

Chairs: Hakan Akbulut, Faruk Aykan

13:05-13:20

  • Clinical Characteristics of RAS Mutant Colorectal Cancers

Anes Pasic

13:20-13:40

  • Optimal Systemic Treatment Strategies for Ras Mutant Colorectal cancer

Marc Peeters

13:40-13:55 Break
13:55–14:55

Session XXI: Localized Rectal Cancer
Chairs: Philip Agop Philip, Cengiz Gemici, Zafer Arik
13:55-14:15

  • Individualizing Adjuvant/ Neoadjuvant Treatment for Rectal Cancer

Ugur Selek

14:15-14:35

  • Surgical Management of Rectal Cancer: Current Approach Future Directions

Oktar Asoglu

14:35-14:55

  • Total Neoadjuvant Treatment and Non Operative Management: Time for Paradigm Shift?

Henning Claus Köhne
Discussion: Vildan Kayku, Bahaddin Yilmaz, Timucin Erol, Pervin Hurmuz

14:55-15:05 Break
15:05-15:45 Novartis Satellite Symposium
Octreotide LAR in Neuroendocrine  Tumor Treatment
Chair: Suayib Yalcin
Speaker:  Nuri Karadurmus
15:45-15:55 Break
15:55–16:35

Session XXII: Update On GIST Tumors

Chairs: Tamer Elkiran, Yesim Eralp

15:55-16:15

  • Understanding the Molecular Biology of GISTs

Tulay Akman

16:15-16:35

  • Update on GIST Management

Ioannis Boukovinas
Discussion: Enver Vardar, Ozlem Ozdemir, Ozden Ozer

16:35-16:45 Break
16:45-17:15

Session XXIII: Increasing Role of NGS in Gastrintestinal Cancer Patients in Clinical Practice

Chairs: Sercan Aksoy, Arzu Yaren

Case Discussions

Sibel Erdamar
Discussion: Ismail Beypinar, Hatice Bolek

17:15-17:30

Break

17:30-18:05

Session XXIV: Advanced Colorectal Cancer: Individualization of Treatment I

Chairs: Nuri Karadurmus, Mehmet Ali Sendur, Ozan Yazici

17:30-17:50

  • Molecular Classification of Colon Cancer: Is It Ready for Clinical Practice?

Ilias Athanasiadis

17:50-18:05

  • Immunoterapies in mCRC: Where Do We Stand Today

Aung Naing
Discussion: Izzet Dogan, Oktay Unsal

18:05-18:20

Break

18:20-19:10

Session XXV: Pancreatic Cancer
Chairs: Fuat Demirelli, Basak Oyan Uluc, Mehmet Alakavuklar
18:20-18:40

  • Adjuvant/Neoadjuvant Treatment in Resectable Pancreas Cancer?

Marwan Ghosn

18:40-18:55

  • Increasing Role of Genetics and Molecular Alterations in the Management of Pancreatic Cancer

Ozcan Yildiz

18:55-19:10

  • Advances in the Systemic Treatment of Pancreatic Cancer

Philip Agop Philip
Discussion: Hacer Gozde Gul

19:10-20:00

Amgen Satellite Symposium
Meet the Expert Meeting
Optimal Systemic Treatment Strategies with Case Discussions in mCRC
Chair: 
Suayib Yalcin
Speaker: 
Ramon Salazar
Case Presentation: 
Osman Kostek

6 December, 2020, Sunday

09:00-10:00

Session XXVI: Rare Gastrointestinal Tumors
Chairs:
İbrahim Barista, Orhan Turken
09:00-09:15

  • Gastric Lymhoma: Ismail Erturk

09:15-09:30

  • Hemangioendotelyoma: Umut Kefeli

         09:30-09:45

  • Small Intestinal Cancer: Yesim Yildirim

         09:45-10:00

  • Appendix Mucinous Nneoplasia: Yasemin Kemal

Discussion: Dicle Aslan

10:00-10:15 Break
10:15-11:00

Session XXVII: Supportive Care in GI Cancers
Chair: Taflan Salepci
10:15-10:30

  • Nause and vomitting

Nilufer Bulut

10:30-10:45

  • Pain Management

        – Altan Sahin
10:45-11:00

  • Principles of Intensive Care in Gastrointestinal Oncology

        – Kaya Yorganci
Discussion: Seniz Tutum, Yalcin Cirak

11:00-11:15 Break
11:15-12:10

Session XXVIII: Cytoreductive Surgery and HIPEC
Chairs: Sabri Barutca, Ugur Yılmaz
11:15-11:30

  • Cytotoxic Regimens Used During Hypertherima

Deniz Can Güven

11:30-11:50

  • Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastrointestinal Cancers

        – Ali Ekrem Unal
11:50-12:05

  • Should We Forget HIPEC: Why Are Studies Failing

        – Fatih Kose

12:05-12:10 Discussion: Ozturk Ates, Merve Kuday

12:10-12:25 Break
12:25-13:25

Session XXIX: We Can Better Understand and Treat Metastatic Colorectal Cancer

Chairs: Ofer Purim, Halil Kavgaci, Ulus Ali Sanli
12:25-12:45

  • Right Versus Left Colon: Mutlu Dogan

12:45-13:05

  • Addressing BRAF Mutant mCRC: Ozkan Kanat

13:05-13:25

  • Controversies on First Line Chemotherapy Regimens: Jesus Garcia Foncillas

Discussion: Ferit Arslan, Hacer Gozde Gul

13:25-13:35 Break
13:35-14:15 BMS Satellite Symposium
Understanding of Emerging Role of Niyolumab in CRC Cancer
Chair:
Gamze Gokoz Dogu
Speaker:
Dilek Erdem
14:15-14:30 Break
14:30–15:20

Session XXX: Special Issues in the Management of GI Cancer-1
Chairs:Turkkan Evrensel. Nuriye Özdemir Yıldırım
14:30-14:45

  • Identifying and Management of Chemotherapy Associated Hepatotoxicity

Ali Alkan

14:45-15:05

  • Identifying and Management of Immune-Related Adverse Reactions

Leyla Ozer

15:05-15:20

  • Addressing Cardiac Toxicity in GI Cancer Patient

Sernaz Uzunoglu

15:20-15:35 Break
15:35-16:50

Session XXXI: Changing Paradigm in Colorectal Cancer

Chairs: Scott Kopetz, Hande Turna, John Souglakos

15:35-15:50

  • Are we There: Neoadjuvant Treatment for Colon Cancer

– Ozlem Yersal

15:50-16:10

  • Understanding the Importance of Tumor Microenvironment in CRC

– Dan Aderka

16:10-16:30

  •  Genomic/Signature Tools for Prediction of Risk in  Earyl Stage Colon Cancer 

– Jesus Garcia Foncillas

16:30-16:50

  • Systemic Therapy for MSI High Colon Cancer

– Huseyin Abali
Discussion: Oguzcan Gumuscubuk, Secil Demirkol Canli

16:50-17:00 Break
17:00-17:55

Session XXXII: New Options and Newer Approaches

Chairs: Necdet Uskent, Anes Pasic

17:00-17:20

  • New Treatment Option for Gastrointestinal Cancers: Trifluridine/Tipiracil Prolongs Survival in 
    Advanced Gastric and Colon Cancer

– Dilek Erdem

17:20-17:40

  • Pharmacogenetics for Colon Cancer

– Ozge Keskin

17:40-17:55

  • Increasing Role of IMRT in GI Cancers

– Cengiz Gemici

Discussion: Merve Kuday, Sedef Hande Aktas, Dicle Aslan

17:55-18:10

Break

18:00-19:40

Session XXXIII: Impact of Precision Medicine in Gastrointestinal Oncology
Chairs: 
Suayib Yalcin, Philip Agop Philip, Ahmed Kaseb

18:10-18:30

  • The Potential Clinical Significance of the CMS Classification

– Dan Aderka

18:30-18:50

  • Role of Immunoscore in Colon and Rectal Cancer

– Claus Henning Kohne

18:50-19:10

  • Role of ctDNA in MRD Detection, Relapse Monitoring and Treatment Response Monitoring in Colon Cancer

– Scott Kopetz

19:10-19:30

  • Accuracy in Clinical Decision in Colon Cancer Setting

– Estelle Cauchin

Discussion: Izzet Dogan, Berrin Papilla Kundaktepe, Sercan On

 19:40-19:50

 Break

  19:50-21:00

Session XXXIV: Panel: Gastrointestinal Cancers  and Nursing Care

Moderator: Duygu Hicdurmaz

19:50-20:00

  • Symptom Control in Gastrointestinal Tumors

– Gulbeyaz Can

20:00-20:10

  • Wound and Stoma Care in Gastrointestinal Tumor Surgery

– Deniz Harputlu

20:10-20:20

  • Psychosocial Care During the Gastrointestinal Cancers Process

– Sinem Uzar Ozcetin 

20:20-20:30

  • Palliative Care in Gastrointestinal Tumors

– Rana Gumus

20:30-20:45

  • Symptom Management in Gastrointestinal Tumors

– Ezgi Bahcivan

Discussion: Merve Keskinkilic, Aysegul Ilhan, Ozden Ozer

 21:00-21:10

 Closing Remarks: Suayib Yalcin